{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:12:00Z","timestamp":1790017920965,"version":"4.0.1"},"reference-count":116,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670088"],"award-info":[{"award-number":["81670088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.isci.2023.107321","type":"journal-article","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T08:04:12Z","timestamp":1689494652000},"page":"107321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Nanotechnology prospects in brain therapeutics concerning gene-targeting and nose-to-brain administration"],"prefix":"10.1016","volume":"26","author":[{"given":"Dong-Dong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine Ahmed","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebenezeri Erasto","family":"Ngowi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadullah","family":"Khattak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazeer Hussain","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Hua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ying","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2023.107321_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.isci.2023.107321_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jamaneurol.2020.4152","article-title":"Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study","volume":"78","author":"Feigin","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.isci.2023.107321_bib3","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.isci.2023.107321_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11427-018-9438-y","article-title":"siRNA therapeutics: a clinical reality","volume":"63","author":"Saw","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.isci.2023.107321_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3097","article-title":"Clinical advances of siRNA therapeutics","volume":"21","author":"Hu","year":"2019","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.isci.2023.107321_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114432","article-title":"The growth of siRNA-based therapeutics: Updated clinical studies","volume":"189","author":"Zhang","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2023.107321_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2023.107321_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.addr.2019.02.008","article-title":"Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential","volume":"148","author":"Agrahari","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.isci.2023.107321_bib9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2174\/1381612043384826","article-title":"New technologies for drug delivery across the blood brain barrier","volume":"10","author":"Kabanov","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.isci.2023.107321_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119491","article-title":"Nanomaterial-based blood-brain-barrier (BBB) crossing strategies","volume":"224","author":"Xie","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.isci.2023.107321_bib11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature09522","article-title":"Pericytes regulate the blood-brain barrier","volume":"468","author":"Armulik","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.isci.2023.107321_bib12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nature09513","article-title":"Pericytes are required for blood-brain barrier integrity during embryogenesis","volume":"468","author":"Daneman","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.isci.2023.107321_bib13","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1096\/fj.01-0814fje","article-title":"Angiogenesis of the blood-brain barrier in\u00a0vitro and the function of cerebral pericytes","volume":"16","author":"Ramsauer","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.isci.2023.107321_bib14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nn.4288","article-title":"Pericytes of the neurovascular unit: key functions and signaling pathways","volume":"19","author":"Sweeney","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.isci.2023.107321_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0847-6","article-title":"Brain microvascular pericytes in health and disease","volume":"122","author":"Dalkara","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.isci.2023.107321_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40259-017-0248-z","article-title":"Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology","volume":"31","author":"Pardridge","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.isci.2023.107321_bib17","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.2174\/1871520617666170713151149","article-title":"Recent Progress of Nano-drug Delivery System for Liver Cancer Treatment","volume":"17","author":"Zhou","year":"2018","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.isci.2023.107321_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/1872211314666191224115211","article-title":"Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective","volume":"13","author":"Qamar","year":"2019","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.isci.2023.107321_bib19","first-page":"233","article-title":"Nano-drug delivery system for the treatment of acute myelogenous leukemia","volume":"51","author":"Zhang","year":"2022","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.isci.2023.107321_bib20","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.2147\/IJN.S252237","article-title":"Burgeoning Polymer Nano Blends for Improved Controlled Drug Release: A Review","volume":"15","author":"Maghsoudi","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.isci.2023.107321_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.isci.2023.107321_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/156720112801323053","article-title":"Polymers and drug delivery systems","volume":"9","author":"Vilar","year":"2012","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.isci.2023.107321_bib23","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1080\/21691401.2017.1290647","article-title":"Liposome-targeted delivery for highly potent drugs","volume":"45","author":"Bardania","year":"2017","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.isci.2023.107321_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120571","article-title":"Design of liposomes as drug delivery system for therapeutic applications","volume":"601","author":"Guimar\u00e3es","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2023.107321_bib25","doi-asserted-by":"crossref","first-page":"22720","DOI":"10.1039\/C8NR07755J","article-title":"Dissociation of fluorescently labeled lipids from liposomes in biological environments challenges the interpretation of uptake studies","volume":"10","author":"M\u00fcnter","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.isci.2023.107321_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: Concepts, development and applications in drug delivery","volume":"252","author":"Singh","year":"2017","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.isci.2023.107321_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3746\/pnf.2019.24.3.225","article-title":"Techniques for Formulation of Nanoemulsion Drug Delivery System: A Review","volume":"24","author":"Kumar","year":"2019","journal-title":"Prev. Nutr. Food Sci."},{"key":"10.1016\/j.isci.2023.107321_bib28","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2174\/1872210514666200604145755","article-title":"Nanoemulsion: A Novel Drug Delivery Approach for Enhancement of Bioavailability","volume":"14","author":"Pandey","year":"2020","journal-title":"Recent Pat. Nanotechnol."},{"key":"10.1016\/j.isci.2023.107321_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: a modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.isci.2023.107321_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.chemphyslip.2014.03.006","article-title":"Drug targeting using solid lipid nanoparticles","volume":"181","author":"Rostami","year":"2014","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.isci.2023.107321_bib31","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijpharm.2017.04.078","article-title":"Nanostructured lipid carriers employing polyphenols as promising anticancer agents: Quality by design (QbD) approach","volume":"526","author":"Bhise","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2023.107321_bib32","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3390\/ijerph13121182","article-title":"Recent Advances on Inorganic Nanoparticle-Based Cancer Therapeutic Agents","volume":"13","author":"Wang","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.isci.2023.107321_bib33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.addr.2019.07.006","article-title":"Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications","volume":"144","author":"Mohammadpour","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.isci.2023.107321_bib34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1021\/nl047950t","article-title":"Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents","volume":"5","author":"Chen","year":"2005","journal-title":"Nano Lett."},{"key":"10.1016\/j.isci.2023.107321_bib35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/ceo.12299","article-title":"Optical coherence contrast imaging using gold nanorods in living mice eyes","volume":"43","author":"de la Zerda","year":"2015","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.isci.2023.107321_bib36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ijpharm.2013.05.031","article-title":"Synthesis and in\u00a0vitro studies of gold nanoparticles loaded with docetaxel","volume":"454","author":"de Oliveira","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2023.107321_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-med-012017-043332","article-title":"Entering the Modern Era of Gene Therapy","volume":"70","author":"Anguela","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.isci.2023.107321_bib38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/nat.2018.0736","article-title":"GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics","volume":"28","author":"Springer","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.isci.2023.107321_bib39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","article-title":"Strategies, design, and chemistry in siRNA delivery systems","volume":"144","author":"Dong","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.isci.2023.107321_bib40","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1080\/10717544.2018.1494225","article-title":"Dual-modified cationic liposomes loaded with paclitaxel and survivin siRNA for targeted imaging and therapy of cancer stem cells in brain glioma","volume":"25","author":"Sun","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.isci.2023.107321_bib41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11481-016-9688-3","article-title":"Electro-Magnetic Nano-Particle Bound Beclin1 siRNA Crosses the Blood-Brain Barrier to Attenuate the Inflammatory Effects of HIV-1 Infection in\u00a0Vitro","volume":"12","author":"Rodriguez","year":"2017","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"key":"10.1016\/j.isci.2023.107321_bib42","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1021\/acsnano.6b03858","article-title":"Neuron-Targeted Nanoparticle for siRNA Delivery to Traumatic Brain Injuries","volume":"10","author":"Kwon","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.isci.2023.107321_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpharm.2014.02.016","article-title":"An apolipoprotein E modified liposomal nanoparticle: ligand dependent efficiency as a siRNA delivery carrier for mouse-derived brain endothelial cells","volume":"465","author":"Tamaru","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2023.107321_bib44","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1021\/nn500704t","article-title":"Bioreducible cationic polymer-based nanoparticles for efficient and environmentally triggered cytoplasmic siRNA delivery to primary human brain cancer cells","volume":"8","author":"Kozielski","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.isci.2023.107321_bib45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/pharmaceutics11030118","article-title":"Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview","volume":"11","author":"Musumeci","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.isci.2023.107321_bib46","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/nn5044838","article-title":"Peptide nanofiber complexes with siRNA for deep brain gene silencing by stereotactic neurosurgery","volume":"9","author":"Mazza","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.isci.2023.107321_bib47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/08820139.2011.604863","article-title":"Suppression of MMP-9 expression in brain microvascular endothelial cells (BMVEC) using a gold nanorod (GNR)-siRNA nanoplex","volume":"41","author":"Mahajan","year":"2012","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.isci.2023.107321_bib48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2018.04.034","article-title":"Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer\u2019s disease","volume":"279","author":"Wang","year":"2018","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.isci.2023.107321_bib49","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.nano.2015.12.374","article-title":"Intranasal brain delivery of cationic nanoemulsion-encapsulated TNF\u03b1 siRNA in prevention of experimental neuroinflammation","volume":"12","author":"Yadav","year":"2016","journal-title":"Nanomedicine."},{"key":"10.1016\/j.isci.2023.107321_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.isci.2023.107321_bib51","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.drudis.2016.10.014","article-title":"miRNA nanotherapeutics for cancer","volume":"22","author":"Ganju","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2023.107321_bib52","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/cns.12840","article-title":"Dysregulation of miRNA and its potential therapeutic application in schizophrenia","volume":"24","author":"Cao","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.isci.2023.107321_bib53","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/jcp.25787","article-title":"MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy","volume":"233","author":"Mirzaei","year":"2018","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.isci.2023.107321_bib54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/IJN.S148142","article-title":"Antitumor effect of a new nano-vector with miRNA-135a on malignant glioma","volume":"13","author":"Liang","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.isci.2023.107321_bib55","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1021\/acs.nanolett.8b00390","article-title":"Bioreducible Polymeric Nanoparticles Containing Multiplexed Cancer Stem Cell Regulating miRNAs Inhibit Glioblastoma Growth and Prolong Survival","volume":"18","author":"Lopez-Bertoni","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.isci.2023.107321_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2016.08.029","article-title":"Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy","volume":"239","author":"Shatsberg","year":"2016","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.isci.2023.107321_bib57","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.omtn.2017.04.010","article-title":"Exosome Mediated Delivery of miR-124 Promotes Neurogenesis after Ischemia","volume":"7","author":"Yang","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.isci.2023.107321_bib58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jmedgenet-2014-102968","article-title":"CRISPR-Cas9: a new and promising player in gene therapy","volume":"52","author":"Xiao-Jie","year":"2015","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.isci.2023.107321_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1609","article-title":"Strategies for nonviral nanoparticle-based delivery of CRISPR\/Cas9 therapeutics","volume":"12","author":"Chen","year":"2020","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.isci.2023.107321_bib60","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10571-019-00761-w","article-title":"CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson\u2019s Disease","volume":"40","author":"Safari","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.isci.2023.107321_bib61","first-page":"371","article-title":"Combination of Genetics and Nanotechnology for Down Syndrome Modification: A Potential Hypothesis and Review of the Literature","volume":"48","author":"Tafazoli","year":"2019","journal-title":"Iran. J. Public Health"},{"key":"10.1016\/j.isci.2023.107321_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201903172","article-title":"Lipopeptide-Based Nanosome-Mediated Delivery of Hyperaccurate CRISPR\/Cas9 Ribonucleoprotein for Gene Editing","volume":"15","author":"Thach","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.isci.2023.107321_bib63","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1038\/s41598-019-40222-4","article-title":"Magnetically guided non-invasive CRISPR-Cas9\/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection","volume":"9","author":"Kaushik","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2023.107321_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(00)00087-7","article-title":"Transport of drugs from the nasal cavity to the central nervous system","volume":"11","author":"Illum","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.isci.2023.107321_bib65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"Erd\u0151","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.isci.2023.107321_bib66","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2174\/156720112803529828","article-title":"Anatomical and histological factors affecting intranasal drug and vaccine delivery","volume":"9","author":"Gizurarson","year":"2012","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.isci.2023.107321_bib67","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1208\/s12248-015-9724-x","article-title":"Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans","volume":"17","author":"Ruigrok","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.isci.2023.107321_bib68","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.antiviral.2011.09.012","article-title":"Brain distribution of ribavirin after intranasal administration","volume":"92","author":"Colombo","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.isci.2023.107321_bib69","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","article-title":"Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs","volume":"281","author":"Agrawal","year":"2018","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.isci.2023.107321_bib70","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1166\/jbn.2018.2581","article-title":"A Novel Delivery System of Cyclovirobuxine D for Brain Targeting: Angiopep-Conjugated Polysorbate 80-Coated Liposomes via Intranasal Administration","volume":"14","author":"Wei","year":"2018","journal-title":"J.\u00a0Biomed. Nanotechnol."},{"key":"10.1016\/j.isci.2023.107321_bib71","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.ijbiomac.2018.05.079","article-title":"Temozolomide loaded nano lipid based chitosan hydrogel for nose to brain delivery: Characterization, nasal absorption, histopathology and cell line study","volume":"116","author":"Khan","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.isci.2023.107321_bib72","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11095-019-2662-z","article-title":"Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma","volume":"36","author":"de Oliveira Junior","year":"2019","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.isci.2023.107321_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110446","article-title":"Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice","volume":"183","author":"Du","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.isci.2023.107321_bib74","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/10717544.2018.1428242","article-title":"In\u00a0vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates","volume":"25","author":"Giuliani","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.isci.2023.107321_bib75","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3233\/JPD-171113","article-title":"Statins and Cognition in Parkinson\u2019s Disease","volume":"7","author":"Deck","year":"2017","journal-title":"J.\u00a0Parkinsons Dis."},{"key":"10.1016\/j.isci.2023.107321_bib76","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.2147\/IJN.S119033","article-title":"The nasal delivery of nanoencapsulated statins - an approach for brain delivery","volume":"11","author":"Clementino","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.isci.2023.107321_bib77","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1567201815666181004094707","article-title":"Nose to Brain Delivery of Galantamine Loaded Nanoparticles: In-vivo Pharmacodynamic and Biochemical Study in Mice","volume":"16","author":"Sunena","year":"2019","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.isci.2023.107321_bib78","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/10717544.2014.907372","article-title":"Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route","volume":"23","author":"Mittal","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.isci.2023.107321_bib79","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/1061186X.2017.1350858","article-title":"Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson\u2019s disease","volume":"26","author":"Sridhar","year":"2018","journal-title":"J.\u00a0Drug Target."},{"key":"10.1016\/j.isci.2023.107321_bib80","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/08982104.2018.1552703","article-title":"Nanostructured cubosomes in an in\u00a0situ nasal gel system: an alternative approach for the controlled delivery of donepezil HCl to brain","volume":"29","author":"Patil","year":"2019","journal-title":"J.\u00a0Liposome Res."},{"key":"10.1016\/j.isci.2023.107321_bib81","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2147\/IJN.S151474","article-title":"Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer\u2019s disease","volume":"13","author":"Meng","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.isci.2023.107321_bib82","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/2211738506666180130105919","article-title":"Formulation and Evaluation of Niosomal in\u00a0situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route","volume":"6","author":"Mathure","year":"2018","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.isci.2023.107321_bib83","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jconrel.2018.12.007","article-title":"inPentasomes: An innovative nose-to-brain pentamidine delivery blunts MPTP parkinsonism in mice","volume":"294","author":"Rinaldi","year":"2019","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.isci.2023.107321_bib84","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12951-017-0277-2","article-title":"Nasal delivery of nanoliposome-encapsulated ferric ammonium citrate can increase the iron content of rat brain","volume":"15","author":"Guo","year":"2017","journal-title":"J.\u00a0Nanobiotechnology"},{"key":"10.1016\/j.isci.2023.107321_bib85","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.3390\/ijms19113306","article-title":"Type 2 Diabetes Mellitus and Alzheimer\u2019s Disease: Role of Insulin Signalling and Therapeutic Implications","volume":"19","author":"Tumminia","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2023.107321_bib86","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2017.11.040","article-title":"Nose-to-brain delivery of insulin enhanced by a nanogel carrier","volume":"270","author":"Picone","year":"2018","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.isci.2023.107321_bib87","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2014.11.004","article-title":"Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides","volume":"197","author":"Kamei","year":"2015","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.isci.2023.107321_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36210-9","article-title":"Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction","volume":"8","author":"Kamei","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2023.107321_bib89","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1208\/s12249-016-0552-9","article-title":"Quetiapine Nanoemulsion for Intranasal Drug Delivery: Evaluation of Brain-Targeting Efficiency","volume":"18","author":"Boche","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.isci.2023.107321_bib90","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2174\/156720112803529792","article-title":"Buffered nanoemulsion for nose to brain delivery of ziprasidone hydrochloride: preformulation and pharmacodynamic evaluation","volume":"9","author":"Bahadur","year":"2012","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.isci.2023.107321_bib91","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijbiomac.2016.03.019","article-title":"Quantification and evaluation of thymoquinone loaded mucoadhesive nanoemulsion for treatment of cerebral ischemia","volume":"88","author":"Ahmad","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.isci.2023.107321_bib92","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijpharm.2017.07.030","article-title":"Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion","volume":"529","author":"Abdou","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2023.107321_bib93","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijpharm.2018.03.055","article-title":"Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in\u00a0vitro","volume":"543","author":"Colombo","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2023.107321_bib94","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3109\/10717544.2015.1092619","article-title":"Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery","volume":"23","author":"Nasr","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.isci.2023.107321_bib95","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejpb.2018.02.010","article-title":"Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles","volume":"127","author":"Trotta","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.isci.2023.107321_bib96","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/10717544.2013.838014","article-title":"Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting","volume":"21","author":"Mahajan","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.isci.2023.107321_bib97","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1021\/mp5008376","article-title":"Comparative Biodistribution and Pharmacokinetic Analysis of Cyclosporine-A in the Brain upon Intranasal or Intravenous Administration in an Oil-in-Water Nanoemulsion Formulation","volume":"12","author":"Yadav","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.isci.2023.107321_bib98","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/27\/2\/025102","article-title":"Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation","volume":"27","author":"Pandey","year":"2016","journal-title":"Nanotechnology"},{"key":"10.1016\/j.isci.2023.107321_bib99","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2174\/1567201813666151202195729","article-title":"Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies","volume":"13","author":"Parikh","year":"2016","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.isci.2023.107321_bib100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/08982104.2014.899369","article-title":"Multifunctional liposomes for nasal delivery of the anti-Alzheimer drug tacrine hydrochloride","volume":"24","author":"Corace","year":"2014","journal-title":"J.\u00a0Liposome Res."},{"key":"10.1016\/j.isci.2023.107321_bib101","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13346-017-0438-8","article-title":"Intranasal delivery of \u03b1-asarone to the brain with lactoferrin-modified mPEG-PLA nanoparticles prepared by premix membrane emulsification","volume":"8","author":"Pan","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.isci.2023.107321_bib102","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s13346-019-00622-5","article-title":"Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles","volume":"9","author":"Nigam","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.isci.2023.107321_bib103","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1208\/s12249-015-0294-0","article-title":"Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles","volume":"16","author":"Sharma","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.isci.2023.107321_bib104","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.xphs.2018.07.013","article-title":"Intranasal Drug Delivery of Frovatriptan Succinate-Loaded Polymeric Nanoparticles for Brain Targeting","volume":"108","author":"Deepika","year":"2019","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.isci.2023.107321_bib105","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s13346-018-0503-y","article-title":"Phospholipid Magnesome-a nasal vesicular carrier for delivery of drugs to brain","volume":"8","author":"Natsheh","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.isci.2023.107321_bib106","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.colsurfb.2012.05.010","article-title":"Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route","volume":"100","author":"Salama","year":"2012","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.isci.2023.107321_bib107","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpharm.2016.02.038","article-title":"Identifying lipidic emulsomes for improved oxcarbazepine brain targeting: In\u00a0vitro and rat in\u00a0vivo studies","volume":"503","author":"El-Zaafarany","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2023.107321_bib108","doi-asserted-by":"crossref","DOI":"10.1515\/ejnm-2014-0022","article-title":"Designing the future of nanomedicine: current barriers to targeted brain therapeutics","volume":"6","author":"Herda","year":"2014","journal-title":"Eur. J. Nanomed."},{"key":"10.1016\/j.isci.2023.107321_bib109","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12987-020-00183-7","article-title":"In\u00a0vitro modeling of the neurovascular unit: advances in the field","volume":"17","author":"Bhalerao","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.isci.2023.107321_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000245","article-title":"Can animal models of disease reliably inform human studies?","volume":"7","author":"van der Worp","year":"2010","journal-title":"PLoS Med."},{"key":"10.1016\/j.isci.2023.107321_bib111","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4155\/tde-2018-0013","article-title":"Nano-carriers for targeted delivery and biomedical imaging enhancement","volume":"9","author":"Parekh","year":"2018","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.isci.2023.107321_bib112","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1471-4159.2001.00541.x","article-title":"Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat","volume":"79","author":"Moos","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.isci.2023.107321_bib113","doi-asserted-by":"crossref","first-page":"84ra44","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2023.107321_bib114","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nano.2008.06.001","article-title":"Drug delivery of siRNA therapeutics: potentials and limits of nanosystems","volume":"5","author":"Reischl","year":"2009","journal-title":"Nanomedicine."},{"key":"10.1016\/j.isci.2023.107321_bib115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4143\/crt.2022.078","article-title":"Challenges in the Use of Targeted Therapies in Non-Small Cell Lung Cancer","volume":"54","author":"Rivera-Concepcion","year":"2022","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.isci.2023.107321_bib116","doi-asserted-by":"crossref","first-page":"183","DOI":"10.22270\/jddt.v10i2-s.4029","article-title":"Nasal In Situ Gel: Novel Approach for Nasal Drug Delivery","volume":"10","author":"Sabale","year":"2020","journal-title":"J.\u00a0Drug Delivery Ther."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223013986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223013986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:25:09Z","timestamp":1762881909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004223013986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":116,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2589004223013986"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2023.107321","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology prospects in brain therapeutics concerning gene-targeting and nose-to-brain administration","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2023.107321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"107321"}}